Breaking News: Longeveron Announces $2.36 Million Registered Direct Offering Priced at Market Value Under NASDAQ Rules
Longeveron Inc. Announces $2.36 Million Registered Direct Offering MIAMI, Dec. 21, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a leading biotechnology company specializing in cellular therapies for life-threatening and chronic aging-related conditions, has recently revealed plans for a $2.36 million registered direct offering. This offering marks a significant milestone for the company as it…